Abstract
Population carrier screening for cystic fibrosis (CF) enables individuals with no known family history of the condition to ascertain their risk of having a child with CF. When an individual is identified as a carrier of CF, a life-shortening condition, they are encouraged to inform their relatives who are at increased risk of being a carrier. Research suggests that the uptake of CF carrier testing amongst relatives of carriers or people with CF is low. This study aimed to explore approaches to facilitate the process of family communication of genetic information after an individual is identified as a carrier of CF through population screening. Five key informants were interviewed to inform the development of a telephone survey which was administered to 21 individuals identified as carriers of CF through population carrier screening at Victorian Clinical Genetics Services. This study suggests that providing carriers with additional information and follow-up support would be appreciated by carriers and could result in more accurate information being disseminated more widely within families, which could lead to more at-risk relatives accessing testing. Suggested strategies to enhance current practice include mailing a fact sheet to carriers and a follow-up telephone call provided by a genetic counsellor to carriers to offer further support in communicating this information to their relatives.
Similar content being viewed by others
References
American College of Obstetricians and Gynecologists Committee on Genetics (2011) ACOG Committee Opinion No. 486: update on carrier screening for cystic fibrosis. Obstet Gynecol 117:1028–1031
Archibald A, McClaren B (2012) Perceived relevance of genetic carrier screening: observations of the role of health-related life experiences and stage of life in decision making. Journal of Community Genetics 3:47–54
Archibald A, Massie J, Smith M, Dalton D, du Start D, Amor D (2014) Population-based genetic carrier screening for cystic fibrosis in Victoria. Med J Aust 200:205–206
Boulton M, Cummings C, Williamson R (1996) The views of general practitioners on community carrier screening for cystic fibrosis. Br J Gen Pract 46:299–301
Castellani C, Massie J (2010) Emerging issues in cystic fibrosis newborn screening. Curr Opin Pulm Med 16:584–590
Claes E, Evers-Kiebooms G, Boogaerts A, Decruyenaere M, Denayer L, Legius E (2002) Communication with close and distant relatives in the context of genetic testing for hereditary breast and ovarian cancer in cancer patients. Am J Med Genet 116A:11–19
Clausen H, Brandt NJ, Schwartz M, Skovby F (1996) Psychological impact of carrier screening for cystic fibrosis among pregnant women. Eur J Hum Genet 4:120–123
Daly M, Barsevick A, Miller S, Buckman R, Costalas J, Montgomery S, Bingler R (2001) Communicating genetic test results to the family: a six-step, skills-building strategy. Family and Community Health 24:13–26
Elo S, Kyngäs H (2008) The qualitative content analysis process. J Adv Nurs 62:107–115
Featherstone K, Atkinson P, Bharadwaj A, Clarke A (2006) Risky relations: family, kinship and the new genetics. Berg, Oxford
Forrest K, Simpson S, Wilson B, van Tejlingen E, McKee L, Haites N, Matthews E (2003) To tell or not to tell: barriers and facilitators in family communication about genetic risk. Clin Genet 64:317–326
Forrest L, Burke J, Bacic S, Amor D (2008) Increased genetic counseling support improves communication of genetic information in families. Genetics in Medicine 10:167–172
Human Genetics Society of Australasia (2010) Cystic fibrosis population screening position paper (document no. PS02). In: Human Genetics Society of Australasia (Ed.) Sydney
Ioannou L, Massie J, Collins V, McClaren B, Delatycki M (2010) Population-based genetic screening for cystic fibrosis: attitudes and outcomes. Public Health Genomics 13:449–456
Ioannou L, Delatycki M, Massie J, Hodgson J, Lewis S (2015) “Suddenly having two positive people who are carriers is a whole new thing”—experiences of couples both identified as carriers of cystic fibrosis through a population-based carrier screening program in Australia. J Genet Couns 24:987–1000
Lafayette D, Abuelo D, Passero M, Tantravahi U (1999) Attitudes toward cystic fibrosis carrier and prenatal testing and utilization of carrier testing among relatives of individuals with cystic fibrosis. J Genet Couns 8:17–36
Lewis D, Curnow L, Ross M, Massie J (2006) Parental attitudes to the identification of their infants as carriers of cystic fibrosis by newborn screening. J Paediatr Child Health 42:533–537
Marshall M (1996) The key informant technique. Fam Pract 13:92–97
Massie J, Clements B (2005) Diagnosis of cystic fibrosis after newborn screening: the Australasian experience—twenty years and five million babies later: a consensus statement from the Australasian paediatric respiratory group. Pediatr Pulmonol 39:440–446
Massie J, Petrou V, Forbes R, Curnow L, Ioannou L, Dusart D, Bankier A, Delatycki M (2009) Population-based carrier screening for cystic fibrosis in Victoria: the first three years experience. Aust N Z J Obstet Gynaecol 49:484–489
McClaren B, Metcalfe S, Aitken MA, Massie J, Ukoumunne O, Amor D (2010) Uptake of carrier testing in families after cystic fibrosis diagnosis through newborn screening. Eur J Hum Genet 18:1084–1089
McClaren B, Metcalfe S, Amor D, Aitken MA, Massie J (2011) A case for cystic fibrosis carrier testing in the general population. Med J Aust 194:208–209
McClaren B, Aitken MA, Massie J, Amor D, Ukoumunne O, Metcalfe S (2013) Cascade carrier testing after a child is diagnosed with cystic fibrosis through newborn screening: investigating why most relatives do not have testing. Genetics in Medicine 15:533–540
McConkie-Rosell A, Robinson H, Wake S, Staley L, Heller K, Cronister A (1995) Dissemination of genetic risk information to relatives in the fragile X syndrome: guidelines for genetic counselors. Am J Med Genet 59:426–430
Myring J, Beckett W, Jassi R, Roberts T, Sayers R, Scotcher D, McAllister M (2011) Shock, adjust, decide: reproductive decision making in cystic fibrosis (CF) carrier couples-a qualitative study. J Genet Couns 20:404–417
Ormond K, Mills P, Lester L, Ross L (2003) Effect of family history on disclosure patterns of cystic fibrosis carrier status. Am J Med Genet 119C:70–77
O'Sullivan B, Freedman S (2009) Cystic fibrosis. Lancet 373:1891–1904
Segal J, Esplen M, Toner B, Baedorf S, Narod S, Butler K (2004) An investigation of the disclosure process and support needs of BRCA1 and BRCA2 carriers. Am J Med Genet 125A:267–272
Sorenson J, Cheuvront B, DeVellis B, Callanan N, Silverman L, Koch G, Sharp T, Fernald G (1997) Acceptance of home and clinic-based cystic fibrosis carrier education and testing by first, second, and third degree relatives of cystic fibrosis patients. Am J Med Genet 70:121–129
Southern K, Littlewood J (2003) Newborn screening programmes for cystic fibrosis. Paediatr Respir Rev 4:299–305
Southern K, Munck A, Pollitt R, Travert G, Zanolla L, Dankert-Roelse J, Castellani C (2007) A survey of newborn screening for cystic fibrosis in Europe. J Cyst Fibros 6:57–65
Super M, Schwarz M, Malone G, Roberts T, Haworth A, Dermody G (1994) Active cascade testing for carriers of cystic fibrosis gene. Br Med J 308:1462–1467
Suthers G, Armstrong J, McCormack J, Trott D (2006) Letting the family know: balancing ethics and effectiveness when notifying relatives about genetic testing for a familial disorder. J Med Genet 43:665–670
Wagener J, Zemanick E, Sontag M (2012) Newborn screening for cystic fibrosis. Current Opinion in Paediatrics 24:329–335
Watson E, Mayall E, Lamb J, Chapple J, Williamson R (1992) Psychological and social consequences of community carrier screening programme for cystic fibrosis. Lancet 340:217–220
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
This study was approved by the Royal Children’s Hospital (RCH) Human Research Ethics Committee (HREC 33267 A) and registered with the University of Melbourne Health Sciences Human Ethics Sub-Committee.
Conflict of interest
The authors declare that they have no conflict of interest.
Human and animal rights and informed consent
This article does not contain any studies with human or animal subjects performed by the any of the authors.
Rights and permissions
About this article
Cite this article
Gorrie, A., Archibald, A.D., Ioannou, L. et al. Exploring approaches to facilitate family communication of genetic risk information after cystic fibrosis population carrier screening. J Community Genet 9, 71–80 (2018). https://doi.org/10.1007/s12687-017-0337-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12687-017-0337-1